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ea urchins have a ﬂuid-ﬁlled body cavity, the coelom,
containing four types of immunocytes called coelo-
mocytes. Within minutes after coelomic ﬂuid is removed
from the body cavity, a massive cell–cell adhesion of coelo-
mocytes occurs. This event is referred to as clotting. Clotting
is thought to be a defense mechanism against loss of coelo-
mic ﬂuid if the body wall is punctured, and it may also
function in the cellular encapsulation of foreign material
and microbes. Here we show that this intercoelomocyte
adhesion is mediated by amassin, a coelomic plasma protein
S
 
with a relative molecular mass (
 
M
 
r
 
) of 75 kD. Amassin
forms large disulﬁde-bonded aggregates that adhere coelo-
mocytes to each other. One half of the amassin protein
comprises an olfactomedin (OLF) domain. Structural pre-
dictions show that amassin and other OLF domain-containing
vertebrate proteins share a common architecture. This
suggests that other proteins of the OLF family may function
in intercellular adhesion. These ﬁndings are the ﬁrst to
demonstrate a function for a protein of the OLF family.
 
Introduction
 
Sea urchin coelomocytes are immune cells contained in
 
the coelomic cavity at 
 
 
 
7.5 
 
 
 
 10
 
6
 
 cells/ml (Coffaro and
Hinegardner, 1977; Smith et al., 1996; Pancer et al., 1999;
Gross et al., 2000; Pancer, 2000). Four major types of coelo-
mocytes are recognized: red amoebocytes (
 
 
 
15%, also
called red spherule cells), colorless amoebocytes (
 
 
 
5%, also
called colorless spherule cells), round vibratile cells with a
single long flagellum (
 
 
 
14%), and phagocytes (
 
 
 
66%)
(Smith et al., 1992). When sea urchin body fluid is removed
from the animal, the coelomocytes rapidly adhere together,
or clot, in a massive intercellular adhesion.
The literature from 1879 to 1959 on the clotting of coelo-
mocytes of all echinoderm classes has been reviewed (Endean,
1966). Johnson (1969) summarized all previous work in
this field and compared it to her observations on the behavior
of sea urchin coelomocytes cultured in hanging drops.
She concluded that clotting was a cell–cell adhesion of
the phagocytic coelomocytes, the other three types of
cells were passively trapped in, or adhered to, the surfaces
of clots. Other results showed that the cell-free plasma
(CFP)* did not form a gel, and clot formation was irre-
versible. A calcium requirement for clotting had been
demonstrated by others (Donnellon, 1938; Bookhout
and Greenburg, 1940; Davidson, 1953). Clotting was
also found to depend on the formation and presence of
disulfide bonds (Boolootian and Giese, 1959; Bertheussen
and Seijelid, 1978). More recent work showed that clotting
was accompanied by a massive rearrangement of the actin
cytoskeleton of the phagocytes that transformed from a
petaloid to a filopodial morphology (Edds, 1977; Otto
and Bryan, 1981).
The clotting of sea urchin coelomocytes is quite different
from the mechanism of blood clotting in mammals (Doolittle,
1984), horseshoe crabs (Tai et al., 1977), and lobsters (Fuller
and Doolittle, 1971) because unlike these other animals the
protein concentration of sea urchin coelomic plasma is low
(0.3–0.7 mg/ml) and varies among individuals and with the
season (Holland et al., 1967). Also, 
 
 
 
50% of the soluble
coelomic protein is a molecule of 
 
 
 
180 kD that is related to
vertebrate transferrin (Brooks and Wessel, 2002) and has no
clotting activity in our assay. We decided to study the bio-
chemistry of clotting of sea urchin coelomocytes in an attempt
to increase the general knowledge concerning different
molecular mechanisms of intercellular adhesion.
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*Abbreviations used in this paper: CFP, cell-free plasma; OLF, olfacto-
medin; PNGase-F, peptide 
 
N
 
-glycosidase-F; WCF, whole coelomic fluid.T
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Results
 
The clotting of coelomocytes
 
The clotting of coelomocytes can be demonstrated by pour-
ing coelomic fluid into a beaker, swirling it gently, and ob-
serving with the unaided eye. Clot formation is visible
within 50 s and is complete by 150 s (Fig. 1). Clots settle
onto the substratum; the cells spread out at the edges of the
clots and appear viable for 1–3 d. To study the biochemistry
of intercoelomocyte adhesion, we devised a reliable method
to prevent clotting. This is accomplished by rapidly mixing
whole coelomic fluid (WCF) with an approximately equal
volume of an isosmotic, buffered calcium chelating solution.
If calcium is then added to the clot-inhibited cells (to 
 
 
 
10
mM), then coelomocyte clotting proceeds normally as if just
removed from the animal. However, if the coelomocytes are
gently sedimented from the clot-inhibited WCF and washed
free of the coelomic plasma, clotting does not occur after the
addition of calcium. The supernatant coelomic plasma after
removal of the cells, termed CFP, induces the clotting of the
washed cells in a concentration-dependent manner (Fig. 2).
Thus, addition of both CFP and calcium to the washed co-
elomocytes is required for clotting.
 
The plasma factor is a protein
 
A standard assay for coelomocyte clotting was developed
(Fig. 2). Sufficient CFP to induce complete clotting was in-
cubated for 10 min at temperatures 23–100
 
 
 
C before being
assayed. A temperature of 70
 
 
 
C abolished clotting activity
(unpublished data). CFP was also incubated for various
times in 0.1 mg/ml pancreatic trypsin at 23
 
 
 
C. Soybean
trypsin inhibitor was added (0.2 mg/ml) to stop the diges-
tion, and the clotting assay was performed. A 2-h digestion
was needed to completely abolish the clotting activity (un-
published data). The heat and protease sensitivity suggested
that the clotting factor is a protein.
 
Identification of the plasma factor
 
CFP from clot-inhibited WCF was obtained and subjected to
ultracentrifugation (150,000 
 
g
 
 for 1 h). Clotting activity was
present in both the supernatant and the pellet; however, there
appeared to be more activity in the pellet. SDS-PAGE separa-
tion of the proteins in the supernatant and the pellet showed
that the pellet had a less complex protein composition. The
ultracentrifuge pellets were solubilized in a buffered salt solu-
tion and subjected to anion exchange chromatography on
DEAE-Sepharose. After washing and eluting with a linear salt
gradient, an aliquot of each fraction was taken and assayed for
clotting activity. Silver-stained gels of the eluted fractions (Fig.
3) showed that the coelomocyte clotting activity was associ-
ated with a diffuse band of 
 
M
 
r
 
 
 
 
 
75 kD (hereafter called
amassin; fractions 10–17). The purity of the 75-kD protein in
Figure 1. The clotting of coelomocytes. Sea urchin coelomocytes 
form a massive cellular clot by rapid intercellular adhesion. The 
contents of the coelomic cavity of one animal was poured into a 
beaker, constantly swirled, and top view photographs were taken. 
(A) After 10 s, aggregates of coelomocytes cannot be seen. (B) After 
50 s, the cells have begun to form aggregations. (C) After 70 s, the 
clot begins to form with stringy cellular masses continuing to adhere 
to each other. (D) By 150 s, clot formation is complete. Bar, 1 cm.
Figure 2. An assay for the level of coelomocyte clotting. The 
degree of coelomocyte clotting depends on the concentration of 
CFP. Complete clotting occurs at 3  g CFP/ml. Data points are the 
mean of five experiments with the same batch of cells (standard 
error bars shown). Clot completion is defined as the level of clotting 
that 10  g CFP would promote compared with no clotting with 
buffer alone.
Figure 3. DEAE-Sepharose chromatography of cell-free coelomic 
plasma. A silver-stained 7.5% SDS-PAGE separation of proteins 
eluting from the DEAE column upon application of a linear salt 
gradient that increases left to right. Numbers on top of lanes represent 
individual fractions. A 10- l aliquot of each fraction was subjected 
to the clotting assay;   denotes the ability to clot, and   fractions 
had no detectable clotting activity. The positive fractions are highly 
enriched for a 75-kD protein called amassin. S, molecular mass 
standards presented in kD.T
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some of the fractions (fractions 12–16) suggested that it is the
only plasma protein required for intercoelomocyte adhesion.
 
Antibody to amassin
 
Approximately 400 
 
 
 
g of amassin was purified by DEAE
chromatography, and rabbit antiserum was raised to the pro-
tein. Specific IgG was affinity purified using a column of the
full-length, bacterially expressed amassin protein (bacterially
expressed amassin does not clot washed coelomocytes). West-
ern blots of CFP showed that the purified antiserum recog-
nized only the amassin band (Fig. 4 A). The whole antiserum
inhibited amassin-induced clotting of coelomocytes, whereas
control serum had no inhibitory activity (Fig. 4 B). Immu-
nofluorescence localization shows that amassin is present be-
tween adhering coelomocytes (Fig. 5). In larger clusters of co-
elomocytes, amassin is seen to bridge distant cells. Only
minimal fluorescence is seen inside coelomocytes.
 
Coelomocyte clotting depends on amassin forming 
disulfide-bonded networks
 
Disulfide bond-reducing agents such as DTT inhibit coelo-
mocyte clotting in the presence of calcium. If reducing
agents such as DTT or 
 
 
 
-mercaptoethanol are excluded
from the SDS-PAGE sample buffer when the components
of CFP are separated by SDS-PAGE, amassin does not enter
the stacking gel (Fig. 6). Treatment of the CFP samples with
different concentrations of reducing agent followed by SDS-
PAGE and Western blotting shows the presence of mono-
mers, dimers, and higher multimers of amassin (Fig. 6).
Clots of coelomocytes were washed with seawater to re-
move coelomic plasma proteins, treated with 20 mM DTT
in seawater at pH 8, and gently agitated. In 
 
 
 
20 min, the
clots dissociated into single cells. The cells were sedimented
by low speed centrifugation, and the supernatant was centri-
fuged at 10,000 
 
g
 
 for 30 min. SDS-PAGE analysis of the re-
sulting supernatant shows that amassin is the major protein
released as a clot and is dissociated by DTT treatment into
single cells (Fig. 7 A). The amassin recovered from clot dis-
sociation was inactive as an inducer of coelomocyte clotting,
showing that reduction of all disulfide bonds might denature
the protein (unpublished data). Amassin is highly enriched
Figure 4. Antibodies to amassin prevent clotting. (A) Western 
blots of CFP show that the antibody reacts only with the 75 kD 
amassin. CFP (5  g) was loaded onto lane 1 and stained with 
Coomassie. The sample for lane 2 was 300 ng CFP and detected 
by Western blot with antiamassin. (B) Preincubation of CFP with 
antiamassin inhibits coelomocyte clotting. Crude antiserum was 
incubated with sufficient CFP to induce complete clotting (3  g/ml) 
for 15 min on ice in a volume of 20  l before adding to washed 
coelomocytes in the clotting assay.
Figure 5. Antibody localizes amassin between adhering 
coelomocytes. The left panels are phase contrast, and the right panels 
are fluorescence with antiamassin. In the top set, amassin binds two 
coelomocytes together. In the bottom two sets, larger groups of 
coelomocytes are shown. Bars, 15  m.
Figure 6. Amassin is disulfide bonded into large aggregates. 
Samples of CFP were incubated with decreasing concentrations of 
DTT (twofold dilutions starting from 100 mM in lane 1 to 24  M in 
lane 13; lane 14 had no DTT) in SDS-PAGE gel loading buffer before 
separation on a 7.5% gel and immunoblotted with antiamassin. If 
disulfide bond-reducing agents are excluded from the sample buffer, 
amassin does not enter the 5% stacking gel (lane 14). Complete 
reduction of disulfides in lane 1 shows the 75-kD reacting band. 
The graded concentration series of DTT displays what can be classified 
as monomers, dimers, and oligomers of amassin.T
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Figure 7. Amassin is released as coelomocyte clots are dissociated 
into single cells. (A) Washed clots were dissociated in DTT, and the 
10,000-g supernatant was recovered (lane 2). A control sample, 
lane 1 is the supernatant released from the same DTT treatment to 
washed, clot-inhibited coelomocytes run on a 10% silver-stained 
SDS-PAGE gel. DTT dissociates the clot into single cells and 
releases amassin. (B) An immunoblot probed with antiamassin. 
Amassin is present in clots of coelomocytes (lane 1), but almost 
undetectable levels (only after long exposures) are present in a 
sample of washed clot-inhibited coelomocytes (lane 2). (C) Samples 
of CFP (300 ng per lane, lane 1 no treatment) were subjected to 
ultracentrifugation either in the absence (lanes 2–3) or presence 
(lanes 4–5) of 10 mM DTT. The resulting supernatants (lanes 2 and 4) 
and pellets (lanes 3 and 5) detected by immunoblot with antiamassin 
show that amassin is present as a large, disulfide-bonded aggregate 
which can be dissociated with DTT.
Figure 8. Confirmation of amassin cloning by recombinant 
protein reactivity and relative molecular mass agreement. (A) The 
bacterial expression of the derived amino acid sequence from the 
amassin OLF domain (aa 228–495) is recognized by the antibodies 
to native amassin. Escherichia coli lysates of preinduced (lane 1) 
and 30 min postinduction (lane 2) are shown stained with 
Coomassie; lanes 3 and 4 are the same samples but immunoblotted 
with antiamassin, which specifically detects the OLF domain of 
the expected size. (B) Amassin is heavily glycosylated. Purified 
amassin was digested with PNGase-F to cleave off the N-linked 
oligosaccharides. SDS-PAGE analysis of the digest (lane 2) showed 
a decrease in Mr relative to the minus enzyme control (lane 1), from 
75 kD to  60 kD.
 
Table I. 
 
Amassin peptide sequences obtained, and corresponding degenerate oligonucleotide primers used to clone cDNA
Peptide sequences (NH
 
2
 
 to COOH termini) Synthetic oligonucleotides (5
 
  
 
to 3
 
 
 
)
Trypsin
 
DIIHVSEPFTVR (229–240) CAYGTIWSIGARCCNTTYAC
GTRAANGGYTCISWIACRTG
IGAWFRDPLQDYIK (246–259) GGIGCNTGGTTYMGNGAYCC
GGRTCNCKRAACCANGCICC
LDPETLDVIETWVAP (380–394) GAYCCNGARACIYTNGAYGT
ACRTCNARIGTYTCNGGRTC
LYGWDNGHQVVYDLTFDPPAR (460–480) TGGGAYAAYGGNCAYCARGT
ACYTGRTGNCCRTTRTCCCA
SQLLPTDTNIPLNLQ (481–495) GAYACIAAYATHCCNYTIAA
TTIARNGGDATRTTIGTRTC
 
Cyanogen bromide
 
RTTSGVV (40–46)
MTLEGVLDGTVVVTVAELELVKEELKEM (117–144)
NH
 
2
 
-terminal peptide sequences obtained following trypsin or cyanogen bromide digestion. Peptide positions within the complete amassin protein sequence
are noted in parentheses. Underlined amino acids represent the region to which the degenerate oligonucleotide primers were directed. Forward (top) and
reverse (bottom) direction oligonucleotides were synthesized. Degenerate positions are denoted as follows: Y 
 
 
 
 C or T, N 
 
 
 
 A or C or G or T, R 
 
 
 
 A or G,
I 
 
 
 
 inosine, M 
 
 
 
 A or C, K 
 
 
 
 G or T, W 
 
 
 
 A or T, S 
 
 
 
 C or G, H 
 
 
 
 A or C or T, D 
 
 
 
 A or G or T.
 
in samples of coelomocytes allowed to clot (followed by
washing) compared with washed clot-inhibited cells (Fig. 7
B). Only after long exposures is a slight detection of amassin
possible in washed coelomocytes. Amassin seems to be most
prominent in the plasma and in clotted coelomocytes.
The data obtained by the use of DTT suggest that amassin
is present in CFP as disulfide-bonded aggregates. A sample
of CFP was divided and one half treated with 10 mM DTT
before ultracentrifugation (200,000 
 
g
 
 for 2 h). A Western
blot of the supernatant and the pellet showed that amassin
was highly enriched in the supernatant of the DTT-treated
sample but undetectable in the nontreated supernatant, in-
dicating that the protein is present in CFP as disulfide-
bonded aggregates (Fig. 7 C).T
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Cloning of the amassin cDNA
 
Using purified amassin, amino acid sequences were obtained
from trypsin and cyanogen bromide-generated peptides.
From this sequence, degenerate primers were designed (Table
I) and used to obtain the complete 1,692 bp cDNA and de-
rived amino acid sequences (sequence data available from
GenBank/EMBL/DDBJ under accession no. AF533649).
There is an 84-bp 5
 
 
 
 untranslated region and a 123-bp 3
 
 
 
 un-
translated region containing a typical AATAAA polyadenyla-
tion signal 4 bp before the poly(A) tract begins. All seven se-
quenced peptides, totaling 112 aa, were found in the derived
amino acid sequence of 495 residues, proving that the correct
cDNA had been cloned. The antibodies made to native
amassin specifically recognize a portion of the amassin se-
quence expressed recombinantly in bacteria (Fig. 8 A).
Amassin has five potential N-linked glycosylation sites, which
probably carry oligosaccharide chains, since digestion with
the enzyme peptide 
 
N
 
-glycosidase-F (PNGase-F) decreases
amassin’s 
 
M
 
r
 
 from 75 to 60 kD (Fig. 8 B), which is close to
the calculated molecular weight of 56.5 kD. The remaining
molecular weight discrepancy could be due to other post-
translational modifications such as O-linked glycosylation.
 
Structural analysis
 
The amassin sequence is similar in the COOH-terminal half
(residues 230–477) to a family of proteins that contain an
olfactomedin (OLF) domain. This domain is found in a va-
riety of extracellular proteins. To investigate amassin’s OLF
domain in more detail, structural predictions were per-
formed using alignments as input for a consensus prediction
method (Fig. 9, A and B). This predicted what would be
classified as an all 
 
 
 
-strand structure for amassin’s OLF do-
main (though one short 
 
 
 
-helix is predicted), which most
likely has a globular conformation. Additionally, by the
same prediction criteria a two 
 
 
 
-strand segment in the NH
 
2
 
-
terminal region (residues 39–59) is predicted (Fig. 9 B). The
all 
 
 
 
 COOH-terminal half containing the OLF domain is in
contrast to the NH
 
2
 
-terminal half of amassin that is pre-
dicted to contain 
 
 
 
-helical coiled-coils from residues 75–
108 and 126–212 (Fig. 9 C). There is also a predicted signal
peptide from residues 1–28
 
.
 
A structural comparison was made between amassin and
four OLF family members: noelin, myocilin/TIGR, tiarin,
and OLF. Using the same prediction criteria, these five pro-
teins share a striking similarity in the presence, size, and or-
der of motifs (Fig. 9 C). All five have a conserved cysteine
(amassin residue 203) at or near the end of the coiled-coil
domain in the proper location of a heptad repeat to form an
interchain disulfide bond (Lupas et al., 1991). Coiled-coils
are common dimerizing motifs, and these are most likely
parallel in orientation with a stabilizing disulfide bond.
Other cysteine positions are also conserved; all five proteins
Figure 9. Analysis of the amassin sequence. Sequence alignment of five OLF family members in only the OLF domains (A) or only the NH2-
terminal  -regions (B). AMAS, amassin; NOEL, noelin-1; MYOC, myocilin; TIAR, tiarin; OLFM, olfactomedin. Amino acid identities are dark 
shaded, similarities are light shaded, and boxes enclose both. Positions which contain cysteines are noted by an asterisk above the alignment. 
Predicted secondary structural motifs are depicted with arrows for  -strands and a cylinder for an  -helix. (C) Comparison of key structural 
motifs in five full-length OLF family members. From NH2 to COOH terminus there is a signal sequence (1), a short  -region (2), a long
coiled-coil motif (3), and the OLF domain (4). All regions containing cysteines are shown. Sequence data for amassin is available from 
GenBank/EMBL/DDBJ under accession no. AF533649.T
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contain 2–3 cysteines within, and just after, the NH
 
2
 
-termi-
nal 
 
 
 
-region (Fig. 9, B and C). Four of the five proteins have
a cysteine just before the first 
 
 
 
-strand of the OLF domain,
and all five have a cysteine at position 407 within the do-
main (Fig. 9 A). With only 19–23% amino acid identity be-
tween amassin and these four other proteins, this structural
comparison provides evidence that these five proteins may
share a similar three-dimensional structure and thus might
have a similar function.
 
Cell surface receptor for amassin
 
Washed coelomocytes were treated with 0.1 mg/ml pancre-
atic trypsin for 30 min followed by the addition of soybean
trypsin inhibitor to a final concentration of 0.2 mg/ml. Cell-
free plasma (9 
 
 
 
g/ml) and calcium (10 mM) was then
added, and the tubes were gently mixed for 10 min. The
cells exposed to trypsin did not clot, suggesting that amassin
binds to a cell surface protein (unpublished data). A control
sample in which trypsin and the inhibitor were added to-
gether for 30 min clotted normally.
 
Discussion
 
Coelomocytes keep the sea urchin free of microorganisms
by binding and phagocytosing foreign materials (Smith et
al., 1992, 1996; Pancer et al., 1999; Clow et al., 2000;
Pancer, 2000). Clotting of coelomocytes is thought to be a
mechanism by which holes are plugged in the sea urchin’s
body wall and microbes and foreign particles are encap-
sulated (Endean, 1966; Johnson, 1969). Until now, the
mechanism of coelomocyte clotting has not been studied
biochemically.
The fact that calcium ions are required for clotting was
known previously (Donnellon, 1938; Bookhout and Green-
burg, 1940; Davidson, 1953), and chelation of calcium has
been employed to block clotting by those studying these
cells (Edds, 1977). This requirement was also found in our
work and used as a means to prevent clotting from occurring
as a first step in studying the process of clotting. Whether
the calcium requirement is involved in exocytosis of a
needed molecule or plays a role in the maintenance of pro-
tein structure or enzyme activation remains unknown.
We have shown here that plasma-free coelomocytes, cal-
cium, and amassin are the only three components needed for
clotting in our in vitro assay. We cannot rule out the in-
volvement of other minor proteins in the plasma, which
might have been present in our purified amassin, although
by silver-staining amassin appears highly purified (Fig. 3).
The mechanism that triggers clotting remains unknown.
An uninjured animal must have a way to keep clotting from
occurring. The washed coelomocytes might have a mecha-
nism to become adhesion competent within seconds after
injury to the coelomic cavity. Since treatment of coelo-
mocytes with protease prevents their ability to clot, a cell
surface protein seems to be involved. This could be a recep-
tor protein which is exposed or activated on the surfaces of
coelomocytes in response to injury. Integrins, which are ex-
pressed on coelomocytes (Burke, 1999), or cell surface lec-
tins would be excellent candidate amassin receptors which
could also regulate downstream signaling events.
Essentially nothing is known about the production of co-
elomocytes by the adult sea urchin. Although the antibody
to amassin does not stain coelomocytes brightly and West-
ern blots of coelomocytes show a weak reaction, amassin
cDNA can be obtained from total coelomocyte RNA, indi-
cating that at least some amassin could be synthesized in co-
elomocytes. Amassin appears to be a minor component of
CFP, since Coomassie-stained SDS gels of CFP show only
minor bands in the 75-kD region. The 180-kD transferrin-
like protein (Brooks and Wessel, 2002) is 
 
 
 
50% of the to-
tal protein in CFP; it does not possess clotting activity in
our assay.
The OLF domain present in amassin is found in many ex-
tracellular proteins including the following: noelin, which
has a neurotropic effect in development with a role in neural
crest formation (Barembaum et al., 2000) and neurogene-
sis (Moreno and Bronner-Fraser, 2001); myocilin/TIGR,
which is thought to have a role in the aqueous outflow of the
vertebrate eye and is often mutated in some forms of glau-
coma (Stone et al., 1997; Nguyen et al., 1998; Fautsch et al.,
2000; Tamm and Russell, 2001); tiarin, a protein mediating
dorsalization of the amphibian neural tube (Tsuda et al.,
2002); and olfactomedin, a protein found in the mucus of
bullfrog olfactory neuroepithelium (Snyder et al., 1991;
Yokoe and Anholt, 1993). Although their roles are being
elucidated, a function for proteins with an OLF domain has
remained unknown.
The previous finding that coelomocytes fail to clot in the
presence of 
 
n
 
-ethyl maleimide (Bertheussen and Seijelid,
1978) and reducing agents (Boolootian and Giese, 1959)
suggested that disulfide bond formation is required for clot-
ting. These observations can be explained by the sensitivity
of amassin to reductants. Clotting, allowed to proceed to
completion, can be reversed by incubation with DTT and in
the process release amassin as the dominant protein (Fig. 7
A). Amassin appears to exist as homooligomers held together
by disulfide bonds; monomers, dimers, and higher multi-
mers resolve on SDS-PAGE depending on the concentration
of disulfide-reducing agent (Fig. 6). The coiled-coil regions
of amassin could be involved in dimer formation. In myoci-
lin/TIGR, the coiled-coil region has been shown by yeast
two-hybrid analysis to possess dimerizing ability (Fautsch
and Johnson, 2001; Wentz-Hunter et al., 2002). The oligo-
merization of the OLF family proteins TIGR (Nguyen et al.,
1998) and olfactomedin (Snyder et al., 1991) has also been
observed. Our structural analysis suggests that the other
OLF family members (Fig. 9 C), known to reside in the ex-
tracellular matrix, might also be involved in formation of
large polymer networks governing cell adhesion in a manner
similar to amassin.
 
Materials and methods
 
Clot inhibition
 
Sea urchins (
 
Strongylocentrotus purpuratus
 
) were maintained in fresh flow-
ing seawater. WCF was obtained by rapid removal of Aristotle’s lantern
(the jaws) and mixing of the coelomic fluid with an approximately equal
volume of clot-inhibiting medium (CIM; 100 mM Hepes, 360 mM NaCl,
10.5 mM KCl, 29 mM Na
 
2
 
SO
 
4
 
, 2 mM NaHCO
 
3
 
, 20 mM EGTA, pH 7.9).
The isosmolarity with seawater of CIM was verified by vapor pressure os-
mometry. After mixing approximately equal portions of WCF and CIM the
resultant pH was 7.5.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
Amassin clots coelomocytes |
 
 Hillier and Vacquier 603
 
Preparation of washed coelomocytes and CFP
 
A three-step centrifugation method was used which sedimented enriched
subpopulations of the four types of coelomocytes and were later com-
bined. This was necessary to minimize damage to the fragile cells from ex-
cessive centrifugation, since the four types differ greatly in density. Clot-
inhibited WCF was centrifuged (4
 
 C) for 2 min at 150 g, which sedimented
the red and colorless amoebocytes (also called spherule cells). The super-
natant was then centrifuged at 150 g for 5 min to sediment the vibratile
cells. Finally, the resulting supernatant was centrifuged at 600 g for 10 min
to sediment the remainder of cells, mostly phagocytes (to prepare CFP, the
supernatant above the sedimented phagocytes was centrifuged at 10,000 g
for 20 min). After removal of the coelomic plasma from each enriched sub-
population, the cells were washed by resuspension in buffered calcium-
free artificial seawater (10 mM Hepes, pH 7.5, 450 mM NaCl, 10.5 mM
KCl, 26 mM MgCl2, 30 mM MgSO4, 2 mM NaHCO3) and resedimented as
before. All three enriched subpopulations were resuspended in buffered
calcium-free artificial seawater and combined at a concentration of 2  
10
6 cells/ml.
Assay for clotting activity
Washed coelomocytes (1 ml) were combined with 20  l of sample to be
tested in a 1.5-ml microcentrifuge tube. One molar CaCl2 was then added
to a final concentration of 10 mM followed by end-over-end rotation for
10 min. Qualitative scoring could be accomplished at this stage by visual
inspection and comparison to controls (buffer only for the negative control
and 10  g unfractionated CFP for the positive control). For a quantitative
measure of degree of clotting, after the 10-min rotation the partially clotted
cell suspension was passed through a nylon mesh of 70  m (Spectra). The
light-scattering ability of the filtrate was then measured at 350 nm and nor-
malized to the same controls to determine fraction clot completion.
Heat and trypsin treatment of CFP
Samples of CFP (0.5 mg/ml) were incubated for 10 min at 23, 37, 42, 50,
70, and 100 C and then added at a final concentration of 5  g/ml to 1 ml
washed coelomocytes and scored for activity. CFP was also incubated for
0, 15, 30, 60, 120, and 240 min in 0.1 mg/ml pancreatic trypsin at 23 C.
Soybean trypsin inhibitor was added (0.2 mg/ml) to stop the digestion, and
the clotting assay was performed.
Purification of amassin
The protein from the CFP of 10 sea urchins (400 ml) was precipitated by ad-
dition of ammonium sulfate to 70% saturation. After centrifugation at
10,000 g (20 min), the pellet was redissolved in 8 ml CIM and centrifuged at
150,000 g for 45 min. The resulting pellet was redissolved in 10 mM Tris,
pH 8, 100 mM NaCl, 0.5 mM EDTA, and loaded onto 10 ml DEAE-Sepha-
rose (Amersham Biosciences) equilibrated in the same buffer. After washing
with 10 column vol, 3-ml fractions were collected during elution with a lin-
ear gradient of NaCl (100–1,000 mM). Pure fractions of amassin were com-
bined and concentrated by stirred cell ultrafiltration (Amicon) with a final
yield of 0.4 mg. Estimating losses at all steps leads to an amassin protein
concentration in the coelomic plasma at  1% of the total plasma protein.
The concentration of total protein in CFP varies from 0.3 to 0.7 mg/ml.
DTT treatment to dissociate clots
Clots were dissociated into single cells by first washing them with excess fil-
tered seawater and then incubating the washed clots in 0.45  m filtered
seawater containing 20 mM DTT and 20 mM Hepes, pH 8, with mild agita-
tion for 20 min. Microscopic observation showed the coelomocytes were
intact after dissociation. The cells were removed by sedimentation at 1,000 g
for 10 min. The supernatant was then centrifuged at 10,000 g for 30 min to
sediment debris. As a control, washed, clot-inhibited coelomocytes were
treated in the same manner with DTT, and the supernatant was isolated.
PNGase-F digestion
Purified amassin (3  g in 10 mM Tris, 200 mM NaCl, and 0.5 mM EDTA)
was brought to 0.5% SDS and 50 mM  -mercaptoethanol in a volume of
10  l and then boiled for 5 min. Five  l of 7.5% NP-40 was added fol-
lowed by 2  l of PNGase-F and 13  l water. The digestion was allowed to
proceed overnight at 37 C.
Antibody preparation
Purified amassin (400  g) was used to raise rabbit antiserum (Strategic Bio-
solutions). Antiserum was affinity purified on a column of bacterially ex-
pressed full-length amassin coupled to Affigel-10 following the manufac-
turer’s directions (Bio-Rad Laboratories).
Cloning amassin sequence
Purified amassin was separated and excised from an SDS-PAGE gel and
sent to the PAN Facility at Stanford University, where tryptic fragments
were generated and sequenced. Additional CNBr-generated fragments were
transferred to PVDF membrane and sequenced at the University of Califor-
nia at San Diego Protein Microsequencing Laboratory. Total RNA was iso-
lated from an entire 7 g sea urchin by homogenization in a Waring blender
with 40 ml of Trizol (Invitrogen) followed by centrifugation at 150 g for 5
min to clear debris. The supernatant was then processed following the man-
ufacturers instructions. PolyA  RNA was purified (Ambion), and first strand
cDNA was synthesized with SuperScript II (Invitrogen) using random hex-
amers. Degenerate primers were designed from the peptide sequence and
used to PCR amplify fragments of the amassin sequence (Table I). From the
sequence of those PCR products, exact match primers were synthesized
and used to complete the 1,692-bp amassin cDNA sequence by 5  and 3 
rapid amplification of cDNA ends (Ambion). Sequence data for amassin is
available from GenBank/EMBL/DDBJ under accession no. AF533649.
Western immunoblots
Proteins were resolved by SDS-PAGE and then transferred to Immobilon-P
membrane (Millipore) in a tank transfer apparatus (Bio-Rad Laboratories).
The membrane was blocked in 5% dry milk in TBST (50 mM Tris, pH 7.5,
150 mM NaCl, 0.05% Tween 20) for 1 h, followed by incubation with a
1:25,000 dilution (0.5 mg IgG/ml stock) of purified antiamassin in blocking
buffer for 1 h, and washed four times for 15 min each. The membrane was
then incubated with goat anti–rabbit IgG HRP-conjugated secondary anti-
body (Jackson ImmunoResearch Laboratories) at a 1:50,000 dilution in
blocking buffer for 1 h, and washed four times for 15 min each. Amassin
was detected with SuperSignal substrate (Pierce Chemical Co.).
Immunofluorescence
Coelomocytes in CIM were allowed to settle onto protamine-coated cover-
slips and were fixed for 45 min in seawater containing 20 mM Hepes, pH
7.5, 0.1% vol/vol glutaraldehyde and 3% wt/vol PFA. After washing, cov-
erslips were blocked in TBST with 1% BSA and 5% normal goat serum. Af-
finity-purified antiamassin was used at various dilutions for 1 h. After
washing, the secondary antibody, Alexa Fluor 546 goat anti–rabbit (Molec-
ular Probes), was applied for 1 h at a 1:400 dilution. Negative controls of
normal rabbit serum and no primary serum had absolutely no fluorescence
after incubation with the Alexa Fluor secondary antibody.
Structural analysis
The five proteins (sequence data available from GenBank/EMBL/DDBJ)
compared are: amassin from Strongylocentrotus purpuratus AF533649, no-
elin-1 from Gallus gallus Q9IAK4 (Barembaum et al., 2000), myocilin/TIGR
from Bos taurus Q9XTA3 (Taniguchi et al., 2000), tiarin from Xenopus lae-
vis BAB85495 (Tsuda et al., 2002), and olfactomedin from Rana catesbei-
ana Q07081 (Yokoe and Anholt, 1993). Assignment OLF domain positions
were obtained with a Pfam search (Bateman et al., 2002). Secondary struc-
ture predictions were performed by using a sequence alignment of the OLF
domains or the NH2-terminal  -regions from the five proteins as input for
the consensus method used by Jpred (Cuff et al., 1998). Signal peptides
were predicted with the web server SignalP (Nielsen et al., 1997). The pro-
gram Coils (Lupas et al., 1991) showed a high probability ( 5 with a win-
dow of 28 residues) for the locations of the  -helical coiled-coils.
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